baber/WOPTO huggingface dataset:
Patent JP-H11503210-A (JP)
Title: 電磁式回転駆動装置を有する回転機器
IPC: A61M60/822
Filed: 1996-04-02
Abstract: (57)【要約】
本回転装置は被動ロータ（２）、電気モータ（４，１４）及び駆動ロータ（）を有する。ステータ（４）は磁気軸受（４，１４）として駆動ロータ（１４）のために構成され、電気モータ（４，１４）の駆動ロータ（１４）は本回転装置の駆動されるロータ（２）を用いてロータユニット（２，１４）、即ち両ロータ（２、１４）は一体型ロータ（２，１４）を構成する。本回転装置は、例えば回転式ポンプ、遠心ポンプ、遠心分離器又は攪拌機であり得る。ロータ（２，１４）はステータ（４）から容易に取り外せるように構成される。
Patent JP-2000506842-A (JP)
Title: 環状イミド―１，３，５―トリアジン架橋剤
IPC: C07D403/14
Filed: 1997-02-27
Abstract: (57)【要約】
少なくとも２個のイミド基を有する１，３，５−トリアジン化合物類及びその製造方法が開示される。また、２個のイミド官能性を有するプレポリマー、並びに、少なくとも２個のイミド基を有する１，３，５−トリアジン化合物又はそのプレポリマーを、活性水素及び／又はエポキシ官能性の物質と組み合わせて含んで成る硬化性組成物も開示される。少なくとも２個のイミド基を有する１，３，５−トリアジン化合物及びプレポリマーは、揮発性の有機化合物の放出を起こさない開環反応によって架橋する架橋剤として有利に用いることができる。
Patent JP-H11505489-A (JP)
Title: 空気圧式制動倍力装置の運転方法
IPC: B60T13/72
Filed: 1997-02-28
Abstract: (57)【要約】
運転者の意志と関係なく特に電磁式に操作可能な制動倍力装置を備えたブレーキ装置の圧力制御の制御範囲を拡張するために、本発明では、制動倍力装置（２）の後に接続配置されたマスタブレーキシリンダ（３）に導入された油圧（Ｐ THt ）が検出され、圧力設定信号（Ｐ Soll ）と比較した後で圧力コントローラ（８）に供給され、この圧力コントローラの出力量（Ｉ St ）が電磁石（７）の制御電流に一致し、リミッタ（１２）に供給され、このリミッタが所望の制御範囲の限界値を決定し、リミッタの出力量（Ｉ Soll ）が電磁石（７）に供給された電流の値と比較され、この比較結果（Ｉ Regel ）が電流コントローラ（１３）に供給され、この電流コントローラが電磁石（７）に印加される電圧（Ｕ EM ）を発生する。
Patent JP-H11503687-A (JP)
Title: 自動車用ブレーキ装置
IPC: B60T13/72
Filed: 1996-03-26
Abstract: (57)【要約】
提案した自動車用ブレーキ装置は、制御可能な空気圧式制動倍力装置を備えている。この制動倍力装置の制御弁は運転者の意志に依存しないで電磁石によって操作可能である。ブレーキ圧力コントローラと制御弁位置コントローラからなる制御構造体は、電磁石に供給される電圧を示す信号を発生する。操作力に比例する減速度制御にブレーキ装置を使用できるようにするために、本発明では、操作ペダル（４）に作用する操作力を示す信号（Ｆ ped ）を発生するための装置（６）が設けられ、この信号がプレフィルタ（２１）に入力量として供給され、このプレフィルタが操作ユニット（１）の動的モデルを含み、プレフィルタの出力量（ｐ soll ）が目標ブレーキ圧力に一致し、圧力オブザーバ（２２）が設けられ、車速を示す信号（ｖ ref ）が入力量として圧力オブザーバに供給され、圧力オブザーバが操作ユニット（１）に接続されたブレーキ装置の部品と車両状態の動的モデルを含み、圧力オブザーバの出力量が、推定されたブレーキ圧力実際値（ｐ ist ）を示し、このブレーキ圧力実際値が制御偏差（Δｐ）を求めるために目標ブレーキ圧力から引算されることが提案される。
Patent JP-H11504633-A (JP)
IPC: A61K38/46
Filed: 1996-04-25
Abstract: Methods and compositions are provided for preventing and/or treating Helicobacter (e.g., H. pylori) infection. The compositions of the invention, which are used in the methods of the invention (which include mucosal administration of the compositions), include compositions containing multimeric complexes of recombinant, enzymatically inactive Helicobacter urease in a pharmaceutically acceptable carrier or diluent; and compositions containing (a) a Helicobacter antigen, and (b) an antibiotic, an antisecretory agent, a bismuth salt, or a combination thereof.
Patent JP-H11505381-A (JP)
IPC: H04N1/04
Filed: 1996-05-02
Abstract: A method of scanning a plurality of images that arranges a portion of an image medium, in a position with a reference mark roughly aligned. The portion of the image medium is scanned to determine the location of the reference mark. The entire image is then scanned immediately after scanning only the portion with the reference mark. A second image is positioned with a reference mark roughly aligned on a scanner. The portion of the second image that has the second reference mark is scanned to determine the location of the second reference mark. The second image medium is repositioned so that the reference mark is placed accurately in the same position of the scanner which was occupied by the first reference mark. The entire second image is then scanned immediately after repositioning the second image medium. The images, and corresponding reference marks, may be recorded in different image media, or in the same medium, such as a single sheet of film. A device according to the invention determines the position of the first and second reference marks, and repositions the second image medium such that the second reference mark coincides with the location which was occupied by a first reference mark.
Patent JP-H11505110-A (JP)
Title: ヒトニューロペプチドレセプター
IPC: C12N15/11
Filed: 1995-05-05
Abstract: (57)【要約】
ヒトニューロペプチドレセプターポリペプチド及びそのポリペプチドをコードするDNA（RNA）並びにそのポリペプチドを組換え技術によって生産する方法が開示されている。また、上記ポリペプチドを上記ポリペプチドに対するアンタゴニスト及びアゴニストの同定に使用する方法と、そのアゴニスト及びアンタゴニストを、それぞれ上記ニューロペプチドレセプターポリペプチドの過少発現及び過剰発現に関係する状態の処置に治療的に使用する方法も開示されている。さらに、そのニューロペプチドレセプター核酸配列中の突然変異及びそのレセプターの可溶型の変化したレベルを検出するための診断法も開示されている。
Patent JP-2000506823-A (JP)
Title: スラストスロット空気コンベヤ
IPC: B65G51/03
Filed: 1997-03-14
Abstract: (57)【要約】
輸送中物品（１６、１１６）を安定化するためのガイド（１２、１２’、１１２ａ、１１２ｂ）、並びに圧縮空気をもたらすための開口（２６、１２６ａ、１２６ｂ）を有するプレナム（２２、１２２ａ、１２２ｂ）を含む空気コンベヤ（１０、１０’、１１０、２１０）が提供される。好ましい態様では、空気コンベヤは、閉じた末端（２１，１３５、１３７）及び開いた末端（２３、１２７、１２９）を有する通路（３４、１３４ａ、１３４ｂ）を画成する相対するスペーサ（３６、１３６ａ、１３６ｂ）も含む。通路は、物品を推進するように下流方向へ開いた末端を経て圧縮空気の流れを物品に導くためにプレナムの開口と流体で連絡する。他の態様では、ガイドのために支持構造物（１４、１４’、１１４ａ、１１４ｂ）で画成されるチャンネルは、物品を推進するように傾いたしかも下流方向の角度で圧縮空気の流れを導くための通路（２８）の一部を形成する。ガイドは取り外し可能で、コンベヤをして異なるサイズ及び形状の物品に適合させる。空気コンベヤは、また物品を下流方向に推進するために追加のプレナム、並びにプレナムと結合した追加の相対するスペーサを含むことができる。
Patent JP-2001509272-A (JP)
Title: マルチウェルプレート
IPC: B01L3/00
Filed: 1998-01-08
Abstract: (57)【要約】
本出願は、マルチウェルアッセイプレート(10)を開示する。このプレートは、周囲縁(12)、格子網(14)、および128×192列のマトリクスで配列された1536の試料ウェル(18)と、16の対照ウェル(20)と、４つの校正ウェル(22)とを有する上側表面(16)を備える。プレート(10)は、射出成形され、相互に垂直の列で配列されたウェルのマトリクスを有する。プレート(10)は、プレート当たり1000より多い試料ウェルのウェル密度を有する。
Patent JP-2000509174-A (JP)
Title: 有価ドキュメント
IPC: G07D7/00
Filed: 1997-04-14
Abstract: (57)【要約】
紙幣のような有価ドキュメントが基材の１つの領域の中又は上にセキュリテイフィーチャー（security feature）を有する。前記セキュリティフィーチャーは少なくとも１つの機械認証可能なハイセキュリティエンティティー（ＨＳＥ）及び低セキュリティエンティティー（ＬＳＥ）又はハイセキュリティエンティティーを含む他の少なくとも１つの機械認証可能なエンティティーを有し、前記少なくとも２つのエンティティーは異なった検出可能な特性を提供する。その又は各ＨＳＥは異なった検出可能な特性を示す少なくとも２つの成分の均質な混合物であり、前記ＬＳＥはＨＳＥによって示される特性とは異なる検出可能な特性を示す単一の成分である有価ドキュメント。
Patent JP-2002510988-A (JP)
Title: 磁気に応答する物質を検出する方法および装置
IPC: G01N27/02
Filed: 1998-02-27
Abstract: (57)【要約】
本発明は、サンプル中の常磁性物質のような供給された磁界に応答する物質（18）を検出する方法および装置である。サンプルは磁界中に位置され、電気導体の性能特性におけるサンプルの影響は物質の存在に相関される。第１の導体（12）はコイルとして構成され、電磁信号源（14）は第１の導体（12）に電流を供給する電流源である。サンプルホルダ（16）中のサンプル（18）は導体（12）の性能に測定可能な影響を有することができる。測定装置（19）はコイル（12）-の予め選択された性能特性の値を測定する。測定装置（19）により測定されたはコンピュータ（30）により表示されてもよい。
Patent JP-2001513798-A (JP)
IPC: A01N37/46
Filed: 1998-03-03
Abstract: Metalaxyl having a high content of R-enantiomer of more than 70 % by weight, or pure R-metalaxyl, in admixture with 3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione ("famoxadone"), exhibits a clearly enhanced fungicidal action against plant diseases compared with a mixture of the same kind in which metalaxyl is used in the form of a racemate.
Patent JP-2001523354-A (JP)
Title: 非平面状基材上での酸化亜鉛膜の製造方法およびその用途
IPC: C03C25/22
Filed: 1998-05-06
Abstract: (57)【要約】
実質的に無指向性の堆積方法および実質的に静止した基材堆積形態を用いて被覆を堆積する工程を含む非平面状基材の上に実質的に連続した周囲被覆を製造する方法が開示される。圧電モジュレーション特性または電気光学モジュレーション特性を有する被覆を堆積することができる。被覆は、理想的には、酸化亜鉛被覆を含む。無指向性堆積方法は、化学蒸着ないしは単一ソース化学蒸着を含み得る。適当な基材には、光ファイバが包含され、光ファイバは、堆積中、実質的に平面状の加熱表面に留められる。光ファイバは、光ファイバの自由末端の動きが実質的に光ファイバの軸に沿った動きに制限されるように、堆積中、加熱表面の一端に配置されたファイバの部分で留められ得る。
Patent JP-2000515609-A (JP)
Title: ポンプノズル
IPC: F02M57/02
Filed: 1998-05-18
Abstract: (57)【要約】
ピストン脚部（３）、ポンプシリンダ（８）、ポンプピストン（７）、中間盤（１６）、ならびに圧力バネ（１４）、圧力バネ板（１５）、およびノズル針(２０)からなる噴射ノズルを備える、特に単気筒ディーゼルエンジン等の内燃機関内に燃料を噴入するためのポンプノズル（１）であり、圧力バネ（１４）をノズル針軸に対して側方にずれて配置することにより、短い長さで構成することが可能となる。
Patent JP-2002509500-A (JP)
IPC: H01M50/10
Filed: 1999-05-26
Abstract: A single piece battery jar and method and apparatus for producing the same employs a stack molding type machine with material injection from the platens. The apparatus can effectively injection mold a one-piece jar with a straight side wall or an undercut side wall. Zero draft capability is also provided. The apparatus also includes an extraction device and core stabilizers. <IMAGE>
Patent MX-148927-A (MX)
Inventor: LEMANSKI MICHAEL FRANCIS
IPC: C07C17/25
Filed: 1978-10-18
Abstract: The present invention relates to a novel catalyst for production of VCM containing a salt of rhodium or platinum, a salt of iron or copper, and a salt of zinc; impregnated on an alumina, titania, zirconia, silica, or silica alumina support.
Patent NZ-193995-A (NZ)
Title: Alpha-carbamoyl-pyrrolpropionitriles and pharmaceutical compositions
Inventor: WALKER G
IPC: C07D207/416
Filed: 1980-06-10
Abstract: Antiinflammatory and antiarthritic compounds of the formula I <IMAGE> in which Pl denotes a 2- or 3-pyrrolyl radical, which is substituted in the 1-position by lower alkyl or Ph-lower alkyl and is unsubstituted in the three remaining positions or substituted by lower alkyl and/or a carboxyl or carboxy-lower alkoxy group; R represents lower alkyl and Ph denotes phenyl which is unsubstituted or substituted by one to three identical or different substituents from the group comprising lower alkyl, lower alkoxy, lower alkylthio, hydroxyl, halogen, trifluoromethyl, nitro, amino or lower alkanoylamino; these compounds in their enol form, their enol lower alkyl ethers or enol lower alkanoyl esters, or their salts with bases can be obtained, for example, by condensation of compounds of the formulae <IMAGE> in which X denotes lower alkoxy, lower alkanoyloxy or halogen.
Patent NZ-201363-A (NZ)
Title: Sulphimine derivatives,and pharmaceutical compositions containing such
Inventor: MULLER E
IPC: A61K31/40
Filed: 1982-07-23
Abstract: Compounds of the formula   <IMAGE>   wherein n is 0 or 1; A is methylene, vinylene or ethylene optionally substituted by lower alkyl; B is alkylene; R1 is an optionally substituted alkyl, phenyl or naphthyl group, or a cycloalkyl or pyridyl group; and R2 is hydrogen or acyl; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as antithrombotics.
Patent NZ-215384-A (NZ)
Title: Sulphur derivatives
Inventor: LEE D L
IPC: C07C63/08
Filed: 1986-03-06
Abstract: Novel trisubstituted benzoic acid intermediates which are useful in the preparation of certain herbicidal 2-(2,3,4- trisubstituted benzoyl)-1,3-cyclohexanediones. The intermediate benzoic acids of this invention have the following structural formula:wherein R<sup>6</sup> is chlorine, C<sub>1</sub>-C<sub>4</sub> alkoxy, C<sub>1</sub>-C<sub>4</sub> alkylthio or hydroxy; n is the integer 0 or 2; and R<sup>7</sup> is C<sub>1</sub>-C<sub>4</sub> alkyl.
Patent NZ-223973-A (NZ)
Title: Pallet accumulating system
Inventor: GLADISH H E
IPC: B65G25/02
Filed: 1988-03-22
Abstract: An accumulation and storage system, preferably for palletized loads, utilizes a SAILRAIL (trade mark) air support system for guiding and supporting an elongated deck (30) during reciprocal movement thereof. Alongside each edge of the deck is a pallet lifting/lowering mechanism (36) which uses an elongated inflatable tube (42), such as a fire hose, top raise or lower an inverted U-shaped lifting member (40). When the lifting members are raised a pallet can be placed thereon and the deck can reciprocate therebelow. When the lifting members are lowered the pallet rests on the deck and can be moved along the system to a subsequent position where it is raised clear of the deck so that the deck can return to pick up another pallet at the input station. Logic controls can be used to operate the system quickly, efficiently and automatically.
Patent NZ-230706-A (NZ)
Title: Pseudomonas strains deregulated for the production of siderophores and methods of controlling deleterious microorganisms
Inventor: O'GARA FERGAL
IPC: C12N15/31
Filed: 1989-09-19
Abstract: Pseudomonas mutant strains which continue to secrete siderophores when iron is present in the growth environment are described. Such strains are suitable for use as biological agents to control microbial pathogens. Also described are DNA fragments containing sequences for iron-mediated regulation of siderophore production in Pseudomonas strains, plasmids containing such DNA fragments and methods of producing Pseudomonas strains deregulated for siderophore production. Also described are methods of controlling the growth of deleterious microorganisms by introducing siderophore onto an environment and maintaining the level thereof to inhibit growth of the microorganisms regardless of the iron concentration in the environment.
Patent NZ-242691-A (NZ)
Title: Advertising panels movable along rails for coupling multiple panels: each panel has information on lamellar body moved between pairs of idlers and drive rollers
Inventor: LOPEZ PEREZ JOSE
IPC: G09F11/18
Filed: 1992-05-11
Abstract: The structure of the display panel is comprised of a frame (1) provided with wheels (2) rolling on rails (3) and wherein is mounted, with the possibility of regulating the inclination, a structure comprised of two side plates (4) and wherein are set two guiding rollers (18) for a laminar body (17) carrying different information, and two rollers (21) for rolling/unrolling said laminar body (17), said rollers being actuated by respective electric motors (22-22') which, appropriately controlled by a computer program, allow to change the information provided by the panel after appropriately predetermined display periods of time. <IMAGE>
Patent NZ-275815-A (NZ)
Title: Reading of physiological assay test strips using transmitted pulsed light
Inventor: CATT MICHAEL
IPC: B01L3/00
Filed: 1994-11-08
Abstract: A method of "reading" the result of an assay effected by concentrating a detectable material in a comparatively small zone of a carrier in the form of a strip, sheet or layer through the thickness of which electromagnetic radiation such as visible light is transmissible, wherein at least a portion of one face or the carrier is exposed to incident electromagnetic radiation which is substantially uniform across the entire portion, the portion including the small zone, and electromagnetic radiation emerging from the opposite face of the carrier is measured to determine the assay result. Preferably the radiation is diffuse light. <IMAGE>
Patent NZ-306445-A (NZ)
Title: Exopolysaccharide degrading enzyme and its use in the treatment of aqueous systems
Inventor: VAN SPEYBROECK MICHEL M P
IPC: B01D61/00
Filed: 1996-04-09
Abstract: The present invention relates to an exopolysaccharide degrading enzyme, to enzymatic compositions capable of degrading exopolysaccharides and in particular to the reduction or removal of biofilm on surfaces and to the prevention of biofilm formation on such surfaces. More particularly, the present invention relates to the use of the enzyme and/or the enzymatic composition, comprising at least one exopolysaccharide degrading enzyme, for the reduction, removal and/or prevention of biofilm on surfaces of aqueous systems (water-bearing systems, fluid systems). The present invention further relates to a bacterial strain producing an exopolysaccharide degrading enzyme, and to the exopolysaccharide degrading enzyme prepared from a newly isolated strain of Streptomyces. Specifically, the exopolysaccharide degrading enzyme of the present invention is a colanic acid degrading enzyme.
Patent NZ-313874-A (NZ)
Title: Compounds used as medicaments useful in eliminating the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus
Inventor: WHITCOMB RANDALL W
IPC: A61K31/427
Filed: 1996-07-29
Abstract: The use, in the manufacture of a medicament for eliminating the need for exogenous insulin administered to a patient having non-insulin dependent diabetes mellitus, of a compound of the above formula, wherein: R1 and R2 are the same or different and each represents a hydrogen atom or a C1-C5 alkyl group; R3 represents a hydrogen atom, a C1-C6 aliphatic acyl group, an alicyclic acyl group, an aromatic acyl group, a heterocyclic acyl group, an araliphatic acyl group, a (C1-C6 alkoxy)carbonyl group, or an aralkyloxycarbonyl group; R4 and R5 are the same or different and each represents a hydrogen atom, a C1-C5 alkyl group or a C1-C5 alkoxy group, or R4 and R5 together represent a C1-C4 alkylenedioxy group; n is 1, 2, or 3; W represents the -CH2-, CO, or CH-OR6 group (in which R6 represents any one of the atoms or groups defined for R3 and may be the same as or different from R3); and Y and Z are the same or different and each represents an oxygen atom or an imino (=NH) group;
Patent NZ-322185-A (NZ)
Title: Diagnosis of coronary artery spasm-associated diseases by screening for changes in the endothelial nitric oxide synthase gene
Inventor: YASUE HIROFUMI
IPC: C12Q1/68
Filed: 1996-11-13
Abstract: The present invention relates to a process for screening for a gene involving a coronary artery spasm-associated disease, which comprises detecting the presence of the relevant nucleotide substituents in the endothelial nitric oxide synthase (eNOS) gene. The present invention provides the ready diagnosis of a coronary artery spasm-associated disease such as angina, which cannot be conveniently screened by the conventional methods.
Patent NZ-509238-A (NZ)
Title: Pulmonary delivery of active agents the carrier containing acylated or sulfonated amino acids
Inventor: O'TOOLE DORIS
IPC: A61K38/095
Filed: 1999-07-27
Abstract: A method of administering a biologically active agent to a non-human animal in need of said agent, by administering via the pulmonary route a composition containing: (a) the active agent (b) a carrier comprising either individually or any combination of: an acylated amino acid, a sulfonated amino acid, a polyamino acid which includes an acylated amino acid, a polyamino acid which includes a sulfonated amino acid.
Patent NZ-509486-A (NZ)
Title: Powder coating compositions with a finely divided wax-coated silica additive
Inventor: RING JOHN
IPC: C09D167/00
Filed: 1999-07-02
Abstract: A powder coating composition which incorporates, by dry blending, a wax coated silica additive in finely divided form. Also described is a process for forming a coating on a substrate.
Patent NZ-512073-A (NZ)
Title: Method for the preparation of 5-cyanophthalide and citalopram
Inventor: PETERSEN HANS
IPC: C07D307/88
Filed: 1999-12-22
Abstract: A method for the preparation of 5-cyanophthalide comprising: i) Conversion of 5-carboxyphthalide (Formula III) to an amide of Formula IV, in which R is H or alkyl. ii) Reacting the amide of formula IV with a dehydrating agent thereby obtaining 5-cyanophthalide (Formula V). Also described is a method for the synthesis of citalopram, comprising the method for the preparation of 5- cyanophthalide described above. Also described is citalopram, when prepared by the above methods.
Patent NZ-512185-A (NZ)
Title: A method for manufacturing glycoproteins having human- type glycosylation in plant cells
Inventor: FUJIYAMA KAZUHITO
IPC: C12N15/09
Filed: 1999-12-08
Abstract: Disclosed herein is a method for manufacturing a glycoprotein having a human-type sugar chain comprising a step in which a transformed plant cell is obtained by introducing to a plant cell the gene of glycosyltransfetase and the gene of an exogenous glycoprotein, and a step in which the obtained transformed plant cell is cultivated.
Patent NZ-512840-A (NZ)
Title: Potentiation of anti-CD38-immunotoxin cytotoxicity
Inventor: ROSENBLUM MICHAEL G
IPC: A61K38/19
Filed: 2000-01-07
Abstract: An immunotoxin directed against CD38 antigen is used in the manufacture of a medicament for the treatment of acute myeloid leukemia, acute promyelocytic leukemia, lymphomas and myelomas in patient which has been previously treated with a retinoid that up-regulates the expression of CD38 antigen. Also described is the use of a composition comprising retinoid which up-regulates the expression of CD38 antigen and an immunotoxin directed against up-regulated CD38 antigen in the manufacture of a medicament for treating acute myeloid leukemia, acute promyelocytic leukemia, lymphomas and myelomas. Preferably the immunotoxin is a monoclonal antibody directed against the CD38 antigen, such as IB4 or IB6, conjugated to a toxin i.e. gelonin.
Patent NZ-520432-A (NZ)
Title: Metal detection device having improved support assembly
Inventor: CLEMENTS PHILIP E
IPC: B65F1/16
Filed: 2000-04-17
Abstract: A support assembly for a metal detection device is disclosed. The detection device includes a housing with a central orifice, an induction member surrounding the orifice for generating an output voltage when a metal object is passed nearby, and a mechanism which includes pulse emitting and pulse receiving members for selectively sensing an object passing through the orifice. The support assembly includes a base member having front, rear and opposed side portions sized and shaped for positioning beneath the housing. The base member has a central aperture adapted for substantial alignment with the housing orifice when the base member is positioned beneath the housing. A mechanism secures the base member to the housing, and a plurality of mounting posts are disposed along the base member front, rear and side portions for positioning a metal detection device induction member about the central aperture. A mounting mechanism is provided for the pulse emitting and pulse-receiving members on opposite sides of the central aperture. Finally, a plurality of pulse regulating elements are provided for eliminating ambient light interference and cross-pulse sensing.
Patent NZ-521119-A (NZ)
Title: Chimeric animal model susceptible to human hepatitis C virus infection
Inventor: KNETEMAN NORMAN M
IPC: C12N7/02
Filed: 2001-03-16
Abstract: Disclosed is a non-human animal model that is susceptible to infection by human hepatotrophic pathogens, particularly human hepatitis C virus (HCV). The model is based on a non-human, immunocompromised xenogeneic transgenic animal having a human-mouse chimeric liver, where the transgene provides for expression of a urokinase- type plasminogen activator in the liver. Also disclosed are methods for identifying candidate therapeutic agents, e.g., agents having antiviral activity against HCV infection
Patent NZ-523562-A (NZ)
Title: Methods of treating cancer and the pain associated therewith using endothelin antagonists
Inventor: JANUS TODD J
IPC: A61K41/00
Filed: 2001-08-06
Abstract: Disclosed is the use of a compound of formula (I), for the manufacture of a medicament for inhibiting bone metastases resulting from breast cancer, prostate cancer, lung cancer, kidney, thyroid cancer, myeloma, lymphoma, sarcoma, osteosarcoma, or ovarian cancer, wherein: R is -(CH2)m-W, Z is -CR18R19- or -C(O)-, R1 and R2 are H, alkyl, alkenyl, alkynyl, alkoxyalkyl, alkoxycarbonylalkyl, hydroxyalkyl, haloalkyl, haloalkoxyalkyl, alkoxyalkoxyalkyl, thioalkoxyalkoxyalkyl, cycloalkyl, cycloalkylalkyl, aminocarbonylalkyl, alkylaminocarbonylalkyl, dialkylaminocarbonylalkyl, aminocarbonylalkenyl, alkylaminocarbonylalkenyl, dialkylaminocarbonylalkenyl, hydroxyalkenyl, aryl, arylalkyl, aryloxyalkyl, arylalkoxyalkyl, (N-alkanoyl-N-alkyl)aminoalkyl, alkylsulfonylamidoalkyl, heterocyclic, (heterocyclic)alkyl, or (Raa)(Rbb)N-Rcc-, R3 is R4-C(O)-R5-, R4-R5a-, R4-C(O)-R5-N(R6)-, R6-S(O)2-R7-R26-S(O)-R27-, R22-O-C(O)-R23-, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyalkyl, aryl, arylalkyl, aryloxyalkyl, heterocyclic, (heterocyclic)alkyl, alkoxyalkylo, alkoxyalkoxyalkyl, or R13-C(O)-CH(R14)-.
Patent NZ-523667-A (NZ)
Title: Crusher
Inventor: AIHARA SHUICHI
IPC: B02C13/18
Filed: 2001-08-08
Abstract: There is provided crusher which can produce uniform finely pulverized material without having to increase the speed of a rotor (1) and which has a good rate of productivity. The crusher comprises crushing vanes (3) having extensions (35) formed protruding radially from the outer surface of the rotor (1) and extending below a material drop point of a dead bed, and an annular wall (5) similarly positioned below the material drop point of a dead bed, on an inner rim of a lower plate (22) of a crushing chamber (2), and pulverizing is effected by crushed material which rebounds and falls from the dead bed, striking the extensions (35) of the crushing vanes (3).
Patent NZ-525275-A (NZ)
Title: Ex vivo oxidatively stressed CLL cells in chronic lymphocytic leukemia (CLL) treatment
Inventor: SPANER DAVID ELLIOTT
IPC: A61K35/14
Filed: 2001-10-25
Abstract: The use in the preparation of a medicament for administration to a patient to alleviate symptoms of chronic lymphocytic leukemia, of compatible, oxidatively stressed malignant chronic lymphocytic leukemia (CLL) cells which have been obtained from the patient, from a compatible mammalism donor or from cultured cell lines and extracorporeally subjected to an oxidizing agent and UV radiation.